| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.60B | +11.8% |
| Cost of Revenue | $1.82B | +3.7% |
| R&D Expense | $2.11B | +34.8% |
| SG&A Expense | $953.3M | +34.1% |
| Operating Income | -$1.40B | -98.7% |
| Interest Expense | $21.5M | +21.4% |
| Pre-tax Income | -$1.40B | -195.3% |
| Income Tax | $29.0M | +113.2% |
| Net Income | -$1.43B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.42B | -28.6% |
| Short-term Investments | $2.52B | +48.1% |
| Accounts Receivable | $1.18B | +10.7% |
| Current Assets | $5.26B | +8.3% |
| Total Assets | $8.03B | +6.5% |
| Current Liabilities | $1.22B | +42.7% |
| Long-term Debt | $3.74B | +66.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $184.6M | -37.0% |
| Capital Expenditures | $129.3M | +85.1% |
| Investing Cash Flow | -$1.06B | -1277.3% |
| Financing Cash Flow | $306.7M | -71.2% |
| Free Cash Flow | $55.3M | -75.2% |
| -193.0% |
| EPS (Basic) | -$0.89 | -187.1% |
| EPS (Diluted) | -$0.89 | -187.1% |
| Total Liabilities |
| $5.45B |
| +45.5% |
| Stockholders' Equity | $2.58B | -31.9% |